Metagenomi Therapeutics, Inc. Common Stock (NASDAQ: MGX) last traded at $1.23, up 2.50% on the session. The quote above updates while this page is open; the figures below are drawn from Metagenomi Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Metagenomi Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker MGX. Its market capitalisation is $46.47 million.
Valuation measures for Metagenomi Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $46.47M |
|---|---|
| Enterprise value | $68.57M |
| Price / sales | 2.08 |
| Price / book | 0.41 |
| Beta | 1.56 |
Trailing-twelve-month figures tagged in Metagenomi Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $22.33M |
|---|---|
| Net income (TTM) | -$93.46M |
| EPS (TTM) | -$2.48 |
| Operating margin | -450.34% |
| Return on equity | -83.03% |
| Cash | $39.03M |
Range and volume for MGX over the past 52 weeks.
| 52-week high | $3.95 |
|---|---|
| 52-week low | $1.13 |
| Volume | 302.4K |
| Average volume | 166.7K |
| Previous close | $1.20 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.